Inhibitex, Inc. (INHX) Tops Q3 EPS by 2c, Sales Double Expectations

November 4, 2011 7:08 AM EDT
Inhibitex, Inc. (NASDAQ: INHX) reported Q3 EPS of ($0.07), $0.02 better than the analyst estimate of ($0.09). Revenue for the quarter came in at $1.26 million versus the consensus estimate of $650 thousand.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings